Vision® 8 Somnus
Clostridium Chauvoei-Septicum-Haemolyticum-Novyi-Sordellii-Perfringens Types C&D Bacterin-Toxoid
*Adjuvant - U.S. Patent Nos. 3,790,665 and 3,919,411
For use in healthy cattle as an aid in prevention of disease caused by Clostridium chauvoel, Clostridium septicum, Clostridium haemolyticum, Clostridium novyi, Clostridium sordellii, Clostridium perfringens
Type C, Clostridium perfringens
Type D, and Haemophilus somnus
Administration and Dosage
The dose is 2 mL for cattle, administered subcutaneously. Repeat the dose in 3-4 weeks. In animals subject to exposure to C. haemolyticum, revaccinate every 5 to 6 months. Annual revaccination is recommended.
Shake well before using. Store at 35-45oF (2-7oC). Use entire contents when first opened. Do not faccinate within 21 days before slaughter. Anaphylactoid reactions may occur.
Epinephrine. Contains formaldehyde as preservative.
Product Label(s) and MSDS
For more information about Merck Animal Health Products call 1-800-441-8272.